08 May 2025
Xbrane Biopharma releases Interim Report January-March 2025
05 May 2025
Announcement from the annual general meeting in Xbrane Biopharma AB
04 May 2025
Invitation to presentation of Xbrane Biopharma’s interim report January – March 2025 on May 8, 2025
14 Apr 2025
Announcement from extra general meeting in Xbrane Biopharma AB
02 Apr 2025
NOTICE OF ANNUAL GENERAL MEETING IN XBRANE BIOPHARMA AB
31 Mar 2025
XBRANE BIOPHARMA RELEASES ANNUAL AND SUSTAINABILITY REPORT FOR 2024
20 Mar 2025
Notice of Extra General Meeting in Xbrane Biopharma AB
20 Mar 2025
Xbrane has entered into an agreement to sell XB003 (Cimzia biosimilar candidate) and parts of its organization to Alvotech for a total consideration of SEK 275 million
20 Feb 2025
Xbrane Biopharma releases Year-end Report 2024